J-Pac offers outsourcing to medical device and diagnostic companies. Headquartered in Somersworth, New Hampshire, it brings more than 35 years of experience providing solutions for OEMs.
J-Pac said it also has experience in complex thermoplastic devices, packaging and in-house tooling capabilities. This allows it to manufacture anatomically correct, Class III implantable textile assemblies, lab-on-chip reagent blisters and complicated thermoformed packaging. The company said it has established a leading presence in the implantable medical textiles and diagnostics end markets.
“J-Pac Medical’s technical know-how and production experience around reagent blister packaging in the molecular diagnostics end-market represents an exciting growth opportunity given trends in point-of-care diagnostics, specifically as it relates to microfluidics and lab-on-a-chip applications,” Jeff Barrett, president of J-Pac’s diagnostics division, said in a news release. “Our partnership with LSO broadens our reach within the life sciences and diagnostics end-markets we are targeting.”
J-Pac Medical operates a 60,000-square-foot, ISO 13485-certified, FDA-registered facility with cleanroom capabilities in New Hampshire. It said it also has strong supplier relationships in Costa Rica.
“J-Pac Medical stood out as a unique and attractive business that aligned perfectly with LSO’s strategic and commercial objectives,” LSO CEO John Nino said in the release. “The company’s capabilities in reagent blister packaging, thermoforming and biomaterials will be additive to LSO’s existing customer base. J-Pac Medical’s assembly, packaging and sterilization capabilities are complimentary to LSO and both will be strengthened by this truly synergistic alliance.”
PPC, the parent company of LSO, acquired the contract manufacturer in January 2021. PPC Operating Partner John Morgan said the combination allows the company to provide a wider array of services to customers across an even broader geographic footprint.